Imidazo[1,2-a]pyrazines as novel PI3K inhibitors
Authors:
- Sonia Martínez GonzálezSGSonia Martínez González
- Ana Isabel HernándezAHAna Isabel Hernández
- Carmen VarelaCVCarmen Varela
- Sonsoles Rodríguez-ArísteguiSRSonsoles Rodríguez-Arístegui
- Rosa María AlvarezRARosa María Alvarez
- Ana Belén GarcíaAGAna Belén García
- Milagros LorenzoMLMilagros Lorenzo
- Virginia RiveroVirginia Rivero
- Julen OyarzabalJOJulen Oyarzabal
- Obdulia RabalORObdulia Rabal
- James R. BischoffJBJames R. Bischoff
- Maribel AlbarránMAMaribel Albarrán
- 1 March 2012
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 22 (5) , 1874-1878
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Chemical Interrogation of FOXO3a Nuclear Translocation Identifies Potent and Selective Inhibitors of Phosphoinositide 3-KinasesJournal of Biological Chemistry, 2009
- Targeting the phosphoinositide 3-kinase pathway in cancerNature Reviews Drug Discovery, 2009
- Regulation of p110δ PI 3-Kinase Gene ExpressionPLOS ONE, 2009
- Essential roles of PI(3)K–p110β in cell growth, metabolism and tumorigenesisNature, 2008
- Synthesis and biological evaluation of pyrido[3′,2′:4,5]furo[3,2-d]pyrimidine derivatives as novel PI3 kinase p110α inhibitorsBioorganic & Medicinal Chemistry Letters, 2007
- Essential role for the p110 isoform in phosphoinositide 3-kinase activation and cell proliferation in acute myeloid leukemiaBlood, 2005
- High Frequency of Mutations of the PIK3CA Gene in Human CancersScience, 2004
- Phosphoinositide 3-kinase signalling – which way to target?Trends in Pharmacological Sciences, 2003
- The Phosphoinositide 3-Kinase PathwayScience, 2002
- Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase BNature, 1995